Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QE3: Coenzyme Q10 in early Parkinson disease
NCT00740714Phase 3Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Dec 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Coenzyme Q10 mucoadhesive tablets in Parkinson's disease (PD), sponsored by Weill Cornell Medicine. Started Dec 2008; status: terminated.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00740714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740714.